LOXL2 and cancer: While untreated conditioned medium increased the migration and invasion, LOXL2 siRNA treatment of cancer-associated fibroblasts significantly decreased the migration and invasion of gastric cancer cells, underlining the tumor promoting role of LOXL2 in tumor-associated stroma cells [39].